Monday, October 26, 2026 · Daily editionET --:--:--

Status not kept up to date

Clinical Study of Endovascular Interventional Surgical Instrument Control System and Related Consumables in Lower Extremity Arteriosclerosis Occlusive Lumen

NCT05625711 · Shanghai Operation Robot Co., Ltd. · Updated 23 Nov 2022

What is being tested
The endovascular interventional surgical instrument control system
For
Peripheral Arterial Disease
Kind of study
Tests a treatment or device on volunteers. No drug phase (a device or procedure study).
Who can join
Ages 18 years to 99 years. About 260 people. The full rules are on the registry page.
Where
Not stated
When
Starts or started 1 Dec 2022, ends 1 Nov 2024. Registered 23 Nov 2022.
Results
None posted yet.

In the researchers' words

This trial was a prospective, multicenter, single-group design. To undergo endovascular treatment of lower extremity arteriosclerosis obliterans After the subjects were selected and enrolled, the surgeons used the endovascular interventional surgical instrument control system developed by Shanghai Aopeng Medical Technology Co., Ltd. and the consumables of the endovascular interventional surgical instrument control system for the interventional hand Instrumentation (guide wire, catheter, stent, balloon) for remote delivery, manipulation, and withdrawal
ClinicalTrials.gov, NCT05625711